Patient-centred Benefit-risk Observational Study of Low-dose Aspirin for CVD (Cardiovascular Disease) and CRC (Colorectal Cancer) Prevention
Patient-centred Benefit-risk Observational Study of Low-dose Aspirin for CVD (Cardiovascular Disease) and CRC (Colorectal Cancer) Prevention
Research shows that low-dose Aspirin prevents diseases of heart and blood vessels as well as cancer of the colon and rectum and it is also associated with risk of bleeding. In this study, they want to learn how patients regard the benefits and risks of low-dose Aspirin for the prevention of these diseases. The researchers also want to learn how patients balance these risks and benefits.
Patient Eligibility Criteria
Inclusion Criteria:
Age and CVD characteristics
Primary prevention:
Secondary prevention:
Able to read and understand Italian
No participation in an investigational program with interventions outside of routine clinical practice
For qualitative interviews:
For pilot/cognitive interviews :
For quantitative main survey:
Exclusion Criteria:
Have glucose-6-phosphate dehydrogenase (G6PD) deficiency (which commonly causes haemolytic anaemia, which is often triggered from eating fava beans, a condition called Favism)
Have the following conditions (which are contraindications to low-dose aspirin)
Concomitant treatment with methotrexate
Cognitive impairment, hearing difficulty, visual impairment, acute psychopathology, or insufficient knowledge of Italian that-in the opinion of the investigator/interviewer-could interfere with a patient's ability to provide written consent and complete an interview or survey
To be currently pregnant
Are pharmaceutical company employees or employed in a position where they have a direct role in treating patients with CVD
Physician Eligibility Criteria:
Multiple Locations, Italy